作者
Liora Lazar,Tal Oron,Michal Yackobovitch‐Gavan,Ariel Tenenbaum,Moshe Phillip,Joseph Meyerovitch,Liat de Vries
摘要
CONTEXT: The long-term health consequences of idiopathic central precocious puberty (ICPP) in males, whether treated or untreated, are not well established. OBJECTIVE: To evaluate general health and metabolic outcomes in adult men with a history of ICPP. DESIGN: Retrospective cohort study with age, birth year, and socioeconomic status-matched controls. PATIENTS: One hundred eighteen men aged 29 to 48 years with a history of ICPP (68 GnRH analog treated, 50 untreated) and 351 matched controls (204 matched to the treated group and 147 to the untreated group). METHODS: Data were extracted from the Clalit Health Services database and included demographics, medical history, medication records, anthropometric data, and laboratory results. MAIN OUTCOME MEASURES: Prevalence of reproductive issues, metabolic conditions (obesity, hypertension, hyperlipidemia, diabetes), osteoporosis, malignancy, and psychopathology. RESULTS: The median age was 40 years in the treated and 44 years in the untreated ICPP group (P < .001). No significant differences were observed between treated and untreated groups in the prevalence of reproductive issues (11.8% vs 18.4%, P = .317), metabolic disorders (35.3% vs 34.7%, P = .946), cardiovascular conditions (16.2% vs 14.3%, P = .780), bone health problems (4.4% vs 4.1%, P = .931), psychopathology (19.1% vs 16.3%, P = .698), or malignancies (1.5% vs 8.2%, P = .160). Reproductive and health outcomes were also comparable between ICPP patients and their respective control groups, regardless of treatment history. CONCLUSION: A history of ICPP in males, whether treated or untreated, does not appear to be associated with adverse long-term outcomes in reproductive, metabolic, emotional, or oncological health. Overall, adult men with prior ICPP exhibit similar health profiles to those of the general population.